Eurofarma Laboratorios

Eurofarma is the first Brazilian multinational pharmaceutical company, established in 1972, and has a strong presence in Latin America. It ranks as the second most prescribed laboratory by the Brazilian medical community and is among the top four generic drug manufacturers in Brazil. The company develops, produces, and commercializes a wide range of pharmaceutical products, including generic and prescription drugs, oncology treatments, and veterinary medicines. Eurofarma boasts the largest medical sales force in Brazil, with approximately 2,000 representatives, and has a significant focus on research and development to enhance its offerings. It operates its own facilities in 15 countries and has over 10 strategically located manufacturing plants. Licenses from third-party products contribute around 10% of its total sales, which reached approximately $1 billion in 2014, reflecting a 20% growth from the previous year. Eurofarma is recognized for its workplace quality and has an ambitious plan for international expansion.

Alexandre Palhares

Vice President of Finance and CFO

3 past transactions

Abcuro

Series B in 2023
Abcuro, Inc. is a biotechnology company focused on developing immunotherapies for the treatment of autoimmunity and cancer. Based in Newton, Massachusetts, Abcuro creates therapeutic antibodies targeting novel mechanisms related to these diseases. The company utilizes advanced bioinformatics to analyze transcription data from human diseases, which aids in the identification of new therapeutic targets. Through ex-vivo validation in diseased tissues, Abcuro seeks to uncover innovative methods to modulate key components of the immune system. Established in 2015, Abcuro aims to enhance treatment strategies in the healthcare industry by offering effective solutions for complex immunological conditions.

JustForYou

Corporate Round in 2022
JustForYou specializes in personalized hair care solutions, focusing on the development of customized formulas for shampoos and conditioners. The company utilizes advanced technology, including Artificial Intelligence, to analyze individual hair needs and create tailored products that enhance hair health. Their offerings include a range of treatments aimed at cleaning, hydrating, and controlling frizz, ensuring that each formulation is scientifically designed to meet the unique requirements of each customer. By combining science with personal care, JustForYou aims to provide effective solutions for hair, nails, and skin, promoting a more conscious approach to beauty products.

Summit Therapeutics

Post in 2020
Summit Therapeutics Inc. is a biopharmaceutical company based in Cambridge, Massachusetts, that specializes in the discovery, development, and commercialization of novel antibiotics aimed at treating serious infectious diseases. The company focuses on addressing Clostridium difficile infection (CDI) with its lead product candidate, ridinilazole, which is currently undergoing Phase III clinical trials. Additionally, Summit is developing the DDS-01 series to combat infections caused by Neisseria gonorrhoeae and the DDS-04 series targeting Enterobacteriaceae. With operations in the United States and Europe, Summit Therapeutics aims to establish new standards of care for patients while creating value for payors and healthcare providers. Founded in 2003, the company is committed to advancing innovative treatments for infectious diseases.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.